Suppr超能文献

生物胺转运体的研究。VI. 用[125I]RTI-55鉴定的一种新型可卡因结合位点在去除尾状核的大鼠全脑制备的膜中的特性。

Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.

作者信息

Rothman R B, Silverthorn M L, Baumann M H, Goodman C B, Cadet J L, Matecka D, Rice K C, Carroll F I, Wang J B, Uhl G R

机构信息

Clinical Pharmacology Section, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland, USA.

出版信息

J Pharmacol Exp Ther. 1995 Jul;274(1):385-95.

PMID:7616423
Abstract

Previous studies showed that the cocaine analog [125I]RTI-55 labels dopamine and serotonergic (5-HT) biogenic amine transporters (BATs) with high affinity. Here we characterized [125I]RTI-55 binding to membranes prepared from whole rat brain minus the caudate nuclei. Paroxetine (50 nM) was used to block [125I]RTI-55 binding to 5-HT transporter sites. Initial experiments identified drugs that displaced [125I]RTI-55 binding with moderately low slope factors. Binding surface analysis of the interaction of 3 beta-(4-chlorophenyl)tropan-2 beta-carboxylic acid phenyl ester hydrochloride (RTI-113) and 3 beta-(4-iodophenyl)tropan-2 beta-carboxylic acid phenyl ester hydrochloride (RTI-122) with [125I]RTI-55 binding sites readily resolved two binding sites for [125I]RTI-55 with Kd values of 0.44 nM and 17 nM and Bmax values of 31 and 245 fmol/mg protein. Potent 5-HT and noradrenergic uptake inhibitors had low affinity for both sites. Whereas cocaine, CFT and WIN35,065-2 were 6.0-, 25- and 14-fold selective for the first site, benztropine, PCP and the novel pyrrole, (+-)-(2RS,3aSR,8bRS)-1,2,3,3a,4,8b-hexahydro- 2-benzyl-1-methylindeno-[1,2-b]pyrrole resorcylate [(+-)-HBMP, formerly called (+-)-RTI-4793-14], were moderately selective for the second site. A single binding site with the characteristics of site 1 was resolved using COS cells transiently expressing the cloned rat dopamine transporter. Lesion studies with 6-hydroxydopamine and 5,7-dihydroxytryptamine were conducted to test the hypothesis that site 1 and site 2 are physically distinct. The data showed that these neurotoxins differentially decreased [125I]RTI-55 binding to sites 1 and 2. The differential distribution of sites 1 and 2 in rat brain provides further support for this hypothesis. Viewed collectively, these data show that [125I]RTI-55 labels a novel binding site in rat brain membranes, termed DATsite2, which is not associated with the classic dopamine, serotonin or norepinephrine transporters.

摘要

先前的研究表明,可卡因类似物[125I]RTI-55能以高亲和力标记多巴胺和血清素能(5-HT)生物胺转运体(BATs)。在此,我们对[125I]RTI-55与从去除尾状核的大鼠全脑制备的膜的结合进行了表征。帕罗西汀(50 nM)用于阻断[125I]RTI-55与5-HT转运体位点的结合。初步实验确定了以适度低斜率因子取代[125I]RTI-55结合的药物。对3β-(4-氯苯基)托烷-2β-羧酸苯酯盐酸盐(RTI-113)和3β-(4-碘苯基)托烷-2β-羧酸苯酯盐酸盐(RTI-122)与[125I]RTI-55结合位点相互作用的结合表面分析很容易解析出[125I]RTI-55的两个结合位点,其Kd值分别为0.44 nM和17 nM,Bmax值分别为31和245 fmol/mg蛋白质。强效的5-HT和去甲肾上腺素摄取抑制剂对这两个位点的亲和力都很低。可卡因、CFT和WIN35,065-2对第一个位点的选择性分别为6.0倍、25倍和14倍,而苯海索、PCP和新型吡咯((+-)-(2RS,3aSR,8bRS)-1,2,3,3a,4,8b-六氢-2-苄基-1-甲基茚并-[1,2-b]吡咯间苯二酚盐[(+-)-HBMP,原称为(+-)-RTI-4793-14])对第二个位点有适度的选择性。使用瞬时表达克隆大鼠多巴胺转运体的COS细胞解析出了具有位点1特征的单个结合位点。用6-羟基多巴胺和5,7-二羟基色胺进行损伤研究,以检验位点1和位点2在物理上是不同的这一假设。数据表明,这些神经毒素对位点1和位点2的[125I]RTI-55结合有不同程度的降低。位点1和位点2在大鼠脑中的差异分布为这一假设提供了进一步支持。综合来看,这些数据表明[125I]RTI-55在大鼠脑膜中标记了一个新的结合位点,称为DATsite2,它与经典的多巴胺、血清素或去甲肾上腺素转运体无关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验